Suppr超能文献

采用质谱法对变应原产品进行质量控制 第一部分:在欧盟监管框架中的定位。

Quality control of allergen products with mass spectrometry part I: Positioning within the EU regulatory framework.

机构信息

Allergology Division, Central Method Development Section, Paul-Ehrlich-Institut, Langen, Germany.

Allergology Division, Allergology Quality Assessment Section, Paul-Ehrlich-Institut, Langen, Germany.

出版信息

Allergy. 2024 Aug;79(8):2088-2096. doi: 10.1111/all.16080. Epub 2024 Feb 29.

Abstract

Mass spectrometry (MS) has advanced greatly and many of its applications are ready for utilization within regulatory procedures and could significantly contribute to overcome challenges in standardization of allergen products. It seems sensible to discuss MS within the regulatory framework, before addressing technical questions. While the application to purified proteins is well established from product development to manufacturer's release analytics, its application to complex products such as allergen products is still under development. It needs to be determined where it can complement or replace established methods or where MS offers limited improvement. Despite its technical appeal and versatility, currently MS is mentioned in regulatory guidelines only as one possible measurement method. For example, no specific MS method is given in the European Pharmacopoeia. We discuss applications of MS within the EU regulatory framework. This includes their advantages and disadvantages and their positioning between research, characterization, manufacturer's release analytics and official batch testing. We discuss the qualitative detection of single and multiple allergens as proof of identity, qualitative to semi-quantitative protein profiles for batch to batch consistency testing, and quantification of allergens to state mass units of allergens. MS may also facilitate standardization of allergen products, reference products and reference standards.

摘要

质谱(MS)技术已经取得了很大的进展,其许多应用已经准备好用于监管程序中,可以为过敏原产品的标准化带来重大贡献。在解决技术问题之前,在监管框架内讨论 MS 似乎是合理的。虽然从产品开发到制造商放行分析,应用于纯化蛋白的 MS 已经得到很好的验证,但它在复杂产品(如过敏原产品)中的应用仍在开发中。需要确定 MS 可以在何处补充或替代已建立的方法,或者 MS 提供的改进有限。尽管 MS 具有技术吸引力和多功能性,但目前仅在监管指南中提到 MS 是一种可能的测量方法。例如,欧洲药典中没有给出具体的 MS 方法。我们讨论了 MS 在欧盟监管框架内的应用。这包括它们的优缺点,以及它们在研究、表征、制造商放行分析和官方批次测试之间的定位。我们讨论了 MS 定性检测单一和多种过敏原以证明其身份、定性到半定量的蛋白质图谱用于批次间一致性测试以及过敏原的定量到过敏原的质量单位。MS 还可以促进过敏原产品、参考产品和参考标准的标准化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验